These findings suggest that BMP9 suppresses the growth of xenograft tumor and inhibits the expression of leptin, p-ERK1/2, p-AKT, p-STAT3, c-Myc, CyclinD1 and MMP9 in vivo. The gene discussed is GDF2; the disease is neoplasm.